Gene Therapy Is Halting Cancer. Can It Work Against Brain Tumors?
New CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
University of California San Francisco
Give to UCSFNew CAR-T gene therapy techniques could extend survival for patients with glioblastoma.
Increased obesity worldwide has become a leading cause of cardiovascular diseases. A new study by UC San Francisco and the Broad Institute of MIT and Harvard researchers found the quantity of fat
A smartphone app could enable greater participation in clinical trials for people with frontotemporal dementia (FTD), a devastating neurological disorder that often manifests in mid-life.
Intentional flu vaccine messaging, such as a brief video, flyer, or a scripted provider question, is enough to persuade many who visit emergency departments to receive the vaccination.
An upcoming Supreme Court ruling could put a stop to telehealth abortion services nationally, and limit access to mifepristone, one of two drugs commonly used in abortion care.
The COVID-19 virus can persist in the blood and tissue of patients for more than a year after the acute phase of the illness has ended.
A first of its kind study finds that the COVID vaccine is safe to administer during pregnancy, causing no abnormal delays when the infants were tested at 12 months and again at 18 months.
Delivering medicine through amniotic fluid is as effective as delivering it to the fetal brain via cerebrospinal fluid to treat serious disordrs such as Angelman syndrome.
UCSF is home to the first center in the world focused on patients with COL4A1/2 mutations, which can cause the rare disease Gould Syndrome.
UCSF will launch the world’s first tissue bank with samples donated by patients with long COVID.
UCSF scientists found a way to predict Alzheimer’s disease up to seven years before symptoms appear by analyzing patient records with machine learning. Conditions that most influenced prediction of Alzheimer’s were high cholesterol and, for women, osteoporosis.
Medication abortion can be delivered safely and effectively through telemedicine, according to new research that comes as the U.S. Supreme Court is about to hear a case that could severely restrict access to one of the two pills that are used to induce abortions.